Literature DB >> 10221325

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

M C Gulliford1, O C Ukoumunne, S Chinn.   

Abstract

The authors estimated components of variance and intraclass correlation coefficients (ICCs) to aid in the design of complex surveys and community intervention studies by analyzing data from the Health Survey for England 1994. This cross-sectional survey of English adults included data on a range of lifestyle risk factors and health outcomes. For the survey, households were sampled in 720 postal code sectors nested within 177 district health authorities and 14 regional health authorities. Study subjects were adults aged 16 years or more. ICCs and components of variance were estimated from a nested random-effects analysis of variance. Results are presented at the district health authority, postal code sector, and household levels. Between-cluster variation was evident at each level of clustering. In these data, ICCs were inversely related to cluster size, but design effects could be substantial when the cluster size was large. Most ICCs were below 0.01 at the district health authority level, and they were mostly below 0.05 at the postal code sector level. At the household level, many ICCs were in the range of 0.0-0.3. These data may provide useful information for the design of epidemiologic studies in which the units sampled or allocated range in size from households to large administrative areas.

Mesh:

Year:  1999        PMID: 10221325     DOI: 10.1093/oxfordjournals.aje.a009904

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  214 in total

Review 1.  Methods in health service research. Evaluation of health interventions at area and organisation level.

Authors:  O C Ukoumunne; M C Gulliford; S Chinn; J A Sterne; P G Burney; A Donner
Journal:  BMJ       Date:  1999-08-07

Review 2.  Zotepine versus other atypical antipsychotics for schizophrenia.

Authors:  Selvizhi Subramanian; Christine Rummel-Kluge; Heike Hunger; Franziska Schmid; Sandra Schwarz; Werner Kissling; Stefan Leucht; Katja Komossa
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 3.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 4.  Design and analysis of group-randomized trials: a review of recent methodological developments.

Authors:  David M Murray; Sherri P Varnell; Jonathan L Blitstein
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

5.  Comparison of intraclass correlation coefficient estimates and standard errors between using cross-sectional and repeated measurement data: the Safety Check cluster randomized trial.

Authors:  Edward H Ip; Richard Wasserman; Shari Barkin
Journal:  Contemp Clin Trials       Date:  2010-11-08       Impact factor: 2.226

Review 6.  Cognitive behavioural therapy (brief versus standard duration) for schizophrenia.

Authors:  Farooq Naeem; Saeed Farooq; David Kingdon
Journal:  Cochrane Database Syst Rev       Date:  2015-10-21

Review 7.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

Review 8.  Crisis intervention for people with severe mental illnesses.

Authors:  Suzanne Murphy; Claire B Irving; Clive E Adams; Ron Driver
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

9.  Diastolic blood pressure and area of residence: multilevel versus ecological analysis of social inequity.

Authors:  J Merlo; P O Ostergren; O Hagberg; M Lindström; A Lindgren; A Melander; L Råstam; G Berglund
Journal:  J Epidemiol Community Health       Date:  2001-11       Impact factor: 3.710

Review 10.  Outcome measures and needs assessment tools for schizophrenia and related disorders.

Authors:  S M Gilbody; A O House; T A Sheldon
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.